Background Patients with HIV infection suffer from accelerated aging. In this context, frailty
could be a relevant problem that aggravates the quality of life (QoL) and morbi-mortality of …

Background Frailty is associated with morbidity and premature mortality among elderly HIV-
uninfected adults, but the determinants and consequences of frailty in HIV-infected …

Background Potent antiretroviral treatment has resulted in near normal life expectancy for
people living with HIV. Consequently, there is an increased focus on comorbidities, frailty …

Background: Frailty is associated with immune activation and inflammation in the elderly
general population, but whether this is true in the younger HIV-infected (HIV+) population is …

Background Frailty is associated with mortality and morbidity in the general geriatric
population, but less is known about its impact among the aging but generally younger …

As the number of older adults with HIV increases, this population is experiencing an
increased risk for frailty. While there is no single definition or diagnostic criteria for frailty, it is …

Background People aging with HIV show variable health trajectories. Our objective was to
identify longitudinal predictors of frailty severity and mortality among a group aging with HIV …

The impact of antiretroviral therapy (ART) on frailty among human immunodeficiency virus
(HIV)–infected adults has not been well described. HIV-infected participants aged≥ 40 …

Background With effective antiretroviral therapy, there is an emerging population of adults
aged 50 years or older with human immunodeficiency virus (HIV). Frailty is an increasingly …

Objectives: Multimorbidity and frailty are consequences of aging with HIV, yet not everyone
with medical disease is frail. Our objective was to identify factors associated with frailty in a …